Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.55) per share. This is a 66.67 percent decrease over losses of $(0.33) per share from the same period last year.
A Global ETF For Stock Investors Looking To Support Democracies Over Authoritarian Regimes
In a world marked by escalating geopolitical dangers, wars, deglobalization threats, and illiberal government policies that harm investors, shifting money away from regimes and toward democracies is the answer to protecting international investments without compromising profits.
